GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSK's Candidate Pre-pandemic Flu Vaccine... (and manufacturecell-culture based season...)

HOME >> MEDICINE >> TECHNOLOGY

GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSK's Candidate Pre-pandemic Flu Vaccine to Start.

Date:8/19/2007

and manufacture cell-culture based seasonal and pandemic influenza vaccines. These cell culture vaccine candidates are not approved in the US.

About GlaxoSmithKline

GSK is one of the world's leading research-based pharmaceutical and health care companies. GSK is committed to improving the quality of human life by enabling people to do more, feel better and live longer. For company information visit: http://www.gsk.com.

About GSK Biologicals

GSK Biologicals, based in Rixensart, Belgium, is the vaccine division of GlaxoSmithKline. As one of the world's leading vaccine manufacturers, GSK Biologicals employs more than 1,500 scientists devoted to discovering new vaccines and developing more cost-effective and convenient combination products to prevent infections that cause serious medical problems.

FluLaval and Fluviral are registered trade marks of the GlaxoSmithKline group of companies.

SOURCE GlaxoSmithKline

1

GOOD

Page: 1 2 3 4
Related medicine technology :

1. GlaxoSmithKline and Genmab Present Positive Phase II Results With ofatumumab in Patients With Rheumatoid Arthritis (RA)
2. GlaxoSmithKline’s Hib-MenCY-TT Combination Vaccine Meets Phase II Study Endpoints of Immunogenicity and Safety Compared to Licensed Vaccines
3. New Data on Genmab and GlaxoSmithKlines Ofatumumab: Phase II Study in Rheumatoid Arthritis to be Presented at EULAR
4. Sirion Therapeutics Receives Orphan Drug Designation for Ophthalmic Drug to Treat Viral Eye Infection
5. Protalix BioTherapeutics, Inc. Receives Approval from the FDA to Initiate a Phase III Clinical Trial of prGCD
6. DUSA Pharmaceuticals Receives Orphan Drug Desi gnation for Levulan PDT to Treat Esophage al Dysplasia
7. Gloucester Pharmaceuticals Receives Fast Track Designation for Romidepsin in Peripheral T-Cell Lymphoma
8. Researchers Discover Gene For Rare Skin Disorder
9. Remarks by President Bush on Stem Cell Veto and Executive Order
10. IMPAX Presents at Movement Disorder Societys 11th International Congress of Parkinsons Disease and Movement Disorders
11. International Movement Disorder Specialists Receive New Information About the Use of Once-Daily Azilect in the Treatment of Parkinsons Disease

Post Your Comments:

(Date:11/25/2009)... ,, NEWYORK,Nov.25/PRNewswire/--Reportlinker...leinitscatalogue: ,, PainManagement-GlobalTre...Pain-Management---Global-Trends.html ,, Widesp...gementclinics,andtheadventofnewdrugshaveaccelerate...rereformsandreimbursementstructurecontinuetoshaped...

(Date:11/25/2009)... ,, FRAMINGHAM,Mass.andSYDNEY,Nov.25/PRNewsw...: HTWR ;ASX:HIN),aleadinginnovatorandproviderofles...esrevolutionizingthetreatmentofadvancedheartfailur...resentationatthe21stAnnualPiperJaffrayHealthCareCo...onferenceisbeingheldattheNewYorkPalaceHotel,Decemb...

(Date:11/24/2009)... ,, PITTSBURGH,Nov.24/PRNewswire/-- ,, WH...r23yearsfollowinganautoaccident,wasactuallyfullyco...odMorningAmericasegment.TheDynaVoxEyeMaxwasfeature...dromeandotherconditionscanunlockcommunication. ,...ailableonlineat www.dynavoxtech.com ,, W...

Breaking Medicine Technology:Reportlinker Adds Pain Management - Global Trends 2 Reportlinker Adds Pain Management - Global Trends 3 Reportlinker Adds Pain Management - Global Trends 4 Reportlinker Adds Pain Management - Global Trends 5 DynaVox EyeMax Featured in Good Morning America Segment About Man Thought To Be in Coma for 23 Years 2 VetCentric Partners with Elanco Animal Health 54326 1 VetCentric Partners with Elanco Animal Health 54326 2 Verizon Wireless Offers Healthy Applications to Turn a Mobile Phone Into a Personal Trainer 54323 1 Verizon Wireless Offers Healthy Applications to Turn a Mobile Phone Into a Personal Trainer 54323 2 New Evidence Based Research Shows that Universal Comprehensive Eye Exams Would Help More Children Succeed in School 54320 1 New Evidence Based Research Shows that Universal Comprehensive Eye Exams Would Help More Children Succeed in School 54320 2 New Evidence Based Research Shows that Universal Comprehensive Eye Exams Would Help More Children Succeed in School 54320 3 New Evidence Based Research Shows that Universal Comprehensive Eye Exams Would Help More Children Succeed in School 54320 4

[0] Reportlinker Adds Pain Management - Global Trends [0] HeartWare to Present at 21st Annual Piper Jaffray Health Care Conference in New York City [0] DynaVox EyeMax Featured in Good Morning America Segment About Man Thought To Be in Coma for 23 Years

...published in,EuroIntervention showed that the expe...ir with the MitraClip(R) system to correct mitral ...ly significant mitral stenosis. Additionally,with ...ed with the,MitraClip(R) system required surgery f...erences were reported between the use of one or tw...

...Clinical Trials , , SAN DIEGO, Dec. 4 VentiR...ny focused on the development of novel Toll-Like R...cer, respiratory and autoimmune diseases, announce...rial of VTX-2337, a selective TLR8 agonist for the...rial is being conducted at the Mayo Clinic Arizona...

Other Medicine Technology:Two-Year Follow-Up Data Demonstrates Preservation of Adequate Mitral Valve Area in Patients Treated with the MitraClip(R) System 2 Two-Year Follow-Up Data Demonstrates Preservation of Adequate Mitral Valve Area in Patients Treated with the MitraClip(R) System 3 Two-Year Follow-Up Data Demonstrates Preservation of Adequate Mitral Valve Area in Patients Treated with the MitraClip(R) System 4 VentiRx Pharmaceuticals Commences Phase I Clinical Trial of VTX-2337, a Novel TLR8 Agonist for the Treatment of Oncology 2

Two-Year Follow-Up Data Demonstrates Preservation of Adequate Mitral Valve Area in Patients Treated with the MitraClip(R) System VentiRx Pharmaceuticals Commences Phase I Clinical Trial of VTX-2337, a Novel TLR8 Agonist for the Treatment of Oncology

(Date:11/26/2009)...enton Communications announces a highly effective ...ilers struggling to make an economic recovery. , ...-- Flu fears is the type of challenge that could s...cording to Dr. David Benton, business growth exper... system – The Rfactor Intensive . “...

(Date:11/25/2009)...25/PRNewswire/--TheBartleHallConventionCenterwillt...ec.9-10,whenKansasCityhoststhelatestinaseriesofmas...cliniceventhasthepotentialtobethebiggestoneyet,bec...ldonweekdaysinsteadofoveraweekend,"SheriWood,execu...identoftheNationalAssociationofFreeClinics(NAFC). ...

(Date:11/25/2009)...wswire/-SentinelleMedicalInc.,aleadingmanufacturer...unchesasuiteofnewleadingedgeclinicalapplicationson...ar,sRadiologicalSocietyofNorthAmerica(RSNA)annualm....Theapplicationsleveragetheuniquehighqualityimages...ndsupportmultipleimagingmodalitiesformulti-paramet...

(Date:11/25/2009)...RNewswire-USNewswire/--TheBlackAIDSInstituterecent...leadershipfor2010. ,, ThenewBoardMembersareahig...icy,law,finance,governmenthealthprograms,editorial...awiderangeofpersonalbackgroundsincludingbothhetero...selves,andrepresentingmultipleagegroups. ,, (Ph...

(Date:11/25/2009)...sticular cancer who were treated with cisplatin-ba...luding neurological side effects and Raynaud-like ...otherapy, according to a new study published onlin...er Institute . , Marianne Brydy, M.D., of the De...l, in Bergen, Norway, and colleagues conducted a c...

Breaking Medicine News(10 mins):Health News:Pharmacist Injects Cure for Ailing Businesses 2 Health News:Kansas City Prepares for Largest Free Health Clinic 2 Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 2 Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 3 Health News:Black AIDS Institute Announces 2010 Board Election Results 2

[1] Pharmacist Injects Cure for Ailing Businesses [1] Kansas City Prepares for Largest Free Health Clinic [1] Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology [0] Black AIDS Institute Announces 2010 Board Election Results [0] News brief: Long-term testicular cancer survivors at high risk for neurological side effects

...ence Call to be held on November 13, 2007 at 8:00 ...eijing/Hong Kong), SHANGHAI, China, Oct. 23 /Xinh...SE: WX ) ("WuXi PharmaTech" or "the Company"), th...nancial results for the third quarter ended Septem...

...Oct. 23 Aflac Incorporated,today reported its thi...e dollar, total revenues rose 5.1% to $3.9,billion...3.7 billion in the,third quarter of 2006. Net earn...t gains of $1 million, or nil per,diluted share, c...

...ich.---Firing clay in unvented kilns could be a si...larly and over long periods, a new study suggests....ith subjects who participated in the University of...naw. , The two-year study, commissioned by Dow Ch...

...ging Identifies Sleep Disorder Without Disturbing ...ly diagnosed by,way of measuring airflow by nasal ...ugh sensors placed in the nose. However, this meth...mbly,of the American College of Chest Physicians (...

.... 23 Two carotid stenting,trials examining outcom...st,time results that are comparable to guidelines ...)(1) for patients treated with carotid artery,surg...ual Transcatheter Cardiovascular Therapeutics (TCT...

...nched to Provide Information and Product Acquisiti...dlines of,the recent tragedies caused by Community... Solutions, LLC, part of the Key Medical Group of,...ucts to combat and kill these superbugs. The websi...

WuXi PharmaTech Schedules 2007 Third Quarter Earnings Release on Monday, November 12, 2007 Aflac Incorporated Announces Third Quarter Results, Declares Fourth Quarter Cash Dividend Firing clay in unvented kilns may be a source of exposure to dioxins Infrared Imaging for Sleep Apnea Diagnosis Shows Promise Real-World Studies of Carotid Artery Stenting Demonstrate Results Comparable to Guidelines for Patients Treated With Surgery Key Cleaning Solutions Products Utilized to Combat Community Acquired - MRSA (CA-MRSA) Are Succeeding In Killing Superbugs Where Normal Cleaning Practices and Products Are Not

...boratory and a worldwide leader in innovative labo...tensive test menu of highly complex and unique med...ed by the University of Utah, ARUP Laboratories' c...ersity teaching hospitals and children's hospitals...

Medicine Products:

Proventil Protoporphyrin, Free Erythrocyte (FEP)Prothrombin Time Prothrombin Nucleotide 20210 G/A Gene Mutation (Factor II)

GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSK's Candidate Pre-pandemic Flu Vaccine...(and manufacturecell-culture based season...),Health